HomeNKB2 • FRA
add
TG Therapeutics Inc common stock
Previous close
€35.26
Day range
€35.92 - €35.92
Year range
€12.37 - €39.85
Market cap
6.55B USD
Avg Volume
127.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 108.18M | 146.04% |
Operating expense | 62.84M | 29.29% |
Net income | 23.33M | 261.84% |
Net profit margin | 21.57 | 165.78% |
Earnings per share | 0.15 | 250.00% |
EBITDA | 29.96M | 340.68% |
Effective tax rate | 8.34% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 311.00M | 42.98% |
Total assets | 577.69M | 75.28% |
Total liabilities | 355.33M | 110.15% |
Total equity | 222.36M | — |
Shares outstanding | 145.23M | — |
Price to book | 22.90 | — |
Return on assets | 12.87% | — |
Return on capital | 16.23% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 23.33M | 261.84% |
Cash from operations | -25.64M | -94.10% |
Cash from investing | 15.79M | 135.28% |
Cash from financing | -6.07M | -607,100.00% |
Net change in cash | -15.92M | 72.53% |
Free cash flow | -30.76M | -122.91% |
About
Founded
1993
Headquarters
Website
Employees
338
